Superworth

ASTROTECH price to sales ratio ASTC

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026
11.1×
10-year median
25.5×
Against its 10-year history
35th
percentile: 0 is its lowest day, 100 its highest
10-year range
3.4× to 182×
Peer median
1.1×

ASTROTECH's price to sales ratio is 11.1× as of Oct 23, 2026.

That is below its ten-year median of 25.5×, lower than on 65% of days in the last ten years.

Over that time it ranged from 3.4× in Mar 2026 to 182× in Dec 2018.

The median for 7 healthcare stocks of a similar size is 1.1×.

Price to sales ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far11.1×3.4×86.9×
20255.1×3.7×27.0×
20249.2×6.5×12.4×
202312.7×11.6×66.3×
202223.5×22.1×91.0×
202188.4×40.8×155×
202052.4×23.6×138×
2019113×56.0×179×
2018182×9.3×182×
201711.4×4.1×14.4×
20168.6×8.6×158×
2015164×4.9×188×
20145.0×1.9×5.4×
20132.3×0.5×2.4×
20120.6×0.5×0.7×

Against its peers

Companies in Healthcare nearest ASTROTECH's size, closest first, today.

CompanyPrice to sales ratio
ASTCASTROTECH11.1×
NEPHNephros1.9×
ATNMActinium Pharmaceuticalsn/m
APTAlpha Pro Tech0.9×
SPROSpero Therapeutics1.4×
LFVNLifevantage0.4×
ICCCImmucell3.0×
KEQUKewaunee Scientific0.3×
Peer median1.1×

Where ASTROTECH ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on ASTROTECH

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.